Govt set to roll out vaccine drive to fight cervical cancer
- The Indian government is set to launch a human papillomavirus (HPV) vaccination campaign to reduce the incidence of cervical cancer.
The HPV Vaccination
- It is planned in three phases over three years, and aims to immunize around 8 crore children.
- It will target girls aged 9-14 to combat cervical cancer, the second most common cancer among Indian women.
- The vaccine also protects against HPV strains causing cancers of the anus, vagina, oropharynx and genital warts.
- Currently priced at Rs 2,000 per dose commercially, it will be available for free once included in the government's immunization program.
Cervical Cancer Burden in India
- India accounts for about a fifth of global cervical cancer cases, with 1.25 lakh new cases and 75,000 deaths annually.
- About 83 percent of invasive cervical cancer cases are attributed to HPV 16 or 18 in India.
Vaccination Logistics
- The immunization drive will be conducted through schools and existing vaccination points.
- Serum Institute of India's indigenously developed quadrivalent vaccine, Cervavac, will be used.
Single-Dose Regimen
- The National Technical Advisory Group on Immunization (NTAGI) recommends ICMR conduct trials on the efficacy of a single-dose regimen in the 9-15 age group.
- While HPV vaccines available globally recommend a two-dose schedule, WHO allows a single-dose regimen for public health programs.
Prelims Takeaway
- HPV Vaccine
- Cervical Cancer
- World Health Organisation (WHO)

